Нові підходи до проблемних питань лікування генітального ендометріозу

In: 2309-4117 · 2014 · W7113048746
article OA: green CC0
🔓 Open OA copy Full text JSON View on OpenAlex
⚙ AI-generated summary by qwen3.7-flash, 2026-09-13 ⓘ

A study of 64 women with endometriosis found that the non-hormonal drug L-arginine (Tivortin) directly impacts underlying factors in disease progression and helps prevent recurrence.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-13 · read from full text ⓘ

This study evaluated the therapeutic effects of L-arginine, administered as the drug Tivortin, in a cohort of 64 women diagnosed with endometriosis. The researchers found that treatment with this non-hormonal agent directly influences the underlying pathological factors driving the development and progression of the disease. Consequently, the authors conclude that L-arginine is a promising option for managing endometriosis and plays a significant role in preventing disease recurrence. This paper is centrally about endometriosis — specifically the use of L-arginine as a non-hormonal treatment to address pathogenic mechanisms and reduce recurrence rates.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The results of the study that involving 64 women with endometriosis have shown that the use in the treatment of L-arginine (the drug Tivortin) has a direct impact on the underlying factors that play role in the development and progression of endometriosis. It makes the use of non-hormonal drug promising in treatment of endometriosis andhas an important role in the prevention of its recurrence.
Full text 6,511 characters · extracted from oa-html · click to expand
New approaches to the treatment of endometriosis DOI: https://doi.org/10.18370/2309-4117.2013.11.36-42Keywords: endometriosis, L-arginine, TivortinAbstract The results of the study that involving 64 women with endometriosis have shown that the use in the treatment of L-arginine (the drug Tivortin) has a direct impact on the underlying factors that play role in the development and progression of endometriosis. It makes the use of non-hormonal drug promising in treatment of endometriosis andhas an important role in the prevention of its recurrence.References - Eskenazi B, Warner MLE pidemiology of endometriosis // ObstetGynecolClin North Am. – 1997. – 24: 235–58. - Johnson N, Hummelshoj L Consensus on current management of endometriosis // Human Reproduction. – 2013. –Vol. 0. – N. 0. – Р. 1–17. - Ziegler D, Borghese B Endometriosis and infertility: pathophysiology and management Review Article // The Lancet. – 2010. – Vol. 376. Issue 9742. – Р. 730–738. - Bulun S Estrogen Receptor-β, Estrogen Receptor-α, and Progesterone Resistance in Endometriosis // SeminReprod Med. – 2010. – 28 (1). – Р. 36–43. - Meng-Hsing Wu Tsai Prostaglandin E2: the master of endometriosis? / Meng-Hsing Wu,Chun-Wun Lu, Pei-Chin Chuang, Shaw-Jenq // Experimental Biology and Medicine. – 2010. – 235. – Р. 668–677. - Capobianco A, Rovere-Querini P Endometriosis, a disease of the macrophage // Frontiers in Immunology and Inflammation. – 2013. – Vol. 4. – Р. 9–12. - Fernando L, Carvalho P Oxidative stress biomarkers in patients with endometriosis: systematic review // Arch Gynecol Obstet. – 2012. – Р. 286: 103. - WahI R, Chan S Identification of Cells with Colony-Forming Activity, Self-Renewal Capacity, and Multipotency in Ovarian Endometriosis // The American Journal of Pathology. – 2011. – Vol. 178. – Issue 6. – Р. 2832–2844. - Sutton CJ Prospective, randomized, double-blind, controlled trial of laser laparoscopy in the treatment of pelvic pain associated with minimal, mild, and moderate endometriosis / Sutton CJ, Ewen SP, Whitelaw N, Haines P // FertilSteril. – 1994. – Vol. 62 (4). – Р. 696–700. - Adamson GD Endometriosis classification: an update // CurrOpinObstet Gynecol. – 2011. – Vol. 23 (4). – Р. 213–20. - Janssen EB Prevalence of endometriosis diagnosed by laparoscopy in adolescents with dysmenorrhea or chronic pelvic pain: a systematic review / EB Janssen, K Hoppenbrouwers, C Meuleman1, TD Hooghe // Hum. Reprod. Update first published online May 31, 2013. - Laschke MW Vasculogenesis: a new piece of the endometriosis puzzle / MW Laschke, C Giebels, M Menger // Human Reproduction Update – 2011. – Vol. 17. – N. 5. – Р. 628–636 - Artini M, Ruggiero F, Papini G, Simi V Cela and AR Genazzani. – 2011. – 256 p. - Taylor R Mechanistic and Therapeutic Implications of Angiogenesis in Endometriosis / R Taylor, Jie Yu, M Torres, A Schickedanz, J Park, M Mueller, N Sidell. – Reprod Sci. – 2009. – Vol. 16 (2). – Р. 140–146. - Van A Langendonckt. Antiangiogenic and vascular-disrupting agents in endometriosis: pitfalls and promises / A Van Langendonckt, J Donnez, S Defre`re1, G Dunselman, P Groothuis // Molecular Human Reproduction. – 2008. – Vol. 14. – N. 5. – Р. 259–268. - Gupta S Role of oxidative stress in endometriosis // Reproductive BioMedicine Online. – 2006. – Vol. 13. – N 1. – Р. 126–134. - Chatterjee S Arginine metabolic pathways determine its therapeutic benefit in experimental heatstroke: Role of Th1/Th2 cytokine balance / S Chatterjee, S Premachandran, R Bagewadikar, S Bhattacharya, S Chattopadhyay, T Poduval // Nitric Oxide. – 2006. – Vol. 15. – Issue 4. – P. 408–416. - Marroni A Consistent interethnic differences in the distribution of clinically relevant endothelial nitric oxide synthase genetic polymorphisms / A Marroni, I Metzger, D Souza-Costa, S Nagassaki, V Sandrim, R Correa // Nitric Oxide. – 2005. – Vol. 12. – Issue 3. – P. 177–182. - Rogers M, D’Amato R Common Polymorphisms in Angiogenesis // Cold Spring Harbor Laboratory Press. – 2013. - Kinugasa S Increased asymmetric dimethylarginine and enhanced inflammation are associated with impaired vascular reactivity in women with endometriosis / S Kinugasa, K Shinohara, A Wakatsuki // Atherosclerosis. – 2011. – Vol. 219. – Issue 2. – P. 784–788. - Cayci T The levels of nitric oxide and asymmetric dimethylarginine in the rat endometriosis model / T Cayci, E Akgul, Y Kurt1 T Ceyhan, I Aydin, O Onguru, H Yaman, E Cakir // Journal of Obstetrics and Gynaecology Research. – 2011. – Vol. 37. – Issue 8. – P. 1041–1047. - Noris M L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species / Noris M, Todeschini M, Cassis P, Pasta F, Cappellini A, Bonazzola S, Macconi D, Maucci R, Porrati F, Benigni A, Picciolo C, Remuzzi G // Hypertension. – 2004. – Vol. 43 (3). – P. 614–622. - López-Jaramillo P Review: The role of the L-arginine-nitric oxide pathway in preeclampsia // TherAdvCardiovasc Dis. – 2008. – Vol. 2. – N. 4. – P. 261–275. - Khan KN Role of prostaglandin E2 in bacterial growth in women with endometriosis // Hum Reprod. – 2012. – Vol. 27 (12). – P. 3417–3424. - Stepanov YM Arginine in medical practice / Stepanov YM, Kononov IN, Zhurbina AI, Filippova AY // J. Academy of Medical Sciences of Ukraine. – 2004. – V. 10. – № 1. – P. 340–352. - Babushkina AB L-arginine from the point of view of evidence-based medicine // Ukrainian Medical Journal. – 2009. – № 6 (74). – P. 21–30. - Lisitsyna NV Medications that affect the synthesis nitric oxide and their place in the pathogenesis of preeclampsia therapy // Scientific Statement of the Belgorod State University. – 2010. – № 10. – Vol. 10. – P. 10–18. Downloads Published How to Cite Issue Section License Copyright (c) 2014 Т. Ф Татарчук, Н. Ф. Захаренко, Т. Н. Тутченко This work is licensed under a Creative Commons Attribution 4.0 International License. Authors who publish with this journal agree to the following terms: - Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. - Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK